Cover Image
市場調查報告書

亞太地區的醫療的R&D投資的推動因素

Drivers for Healthcare R&D Investment in Asia-Pacific

出版商 Frost & Sullivan 商品編碼 323416
出版日期 內容資訊 英文 12 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
亞太地區的醫療的R&D投資的推動因素 Drivers for Healthcare R&D Investment in Asia-Pacific
出版日期: 2015年01月22日 內容資訊: 英文 12 Pages
簡介

醫療保健產業上的研究開發(R&D)投資,是維持革新,促進成長的關鍵。

本報告提供亞太地區的醫療的R&D投資相關研究,主要以澳洲、新加坡、韓國為對象,提供有系統的資訊。

目錄

  • 簡介
  • 摘要整理
  • 亞洲:新興R&D中心
  • 增加亞太地區的R&D投資的推動因素
  • 結論
  • 參照
  • 免責聲明
  • 關於Frost&Sullivan
目錄
Product Code: 9837-00-A8-00-00

Rise of the APAC R&D Giants

Investments in Research and Development (R&D) is the key to sustaining innovation and promoting growth in the healthcare industry. Between 2007 and 2012, global investment in R&D in the industry took a detour from US and Europe towards Asia-Pacific (APAC) countries, primarily targeting Australia, Singapore, and South Korea. This research report presents a high-level chronicling of the events and transitions that have led to this trend-the emergence of APAC as a prominent R&D hub.

Table of Contents

  • Introduction
  • Executive Summary
  • Asia: An Emerging R&D Hub
  • Drivers for Increasing R&D Investment in APAC
  • Conclusion
  • References
  • Legal Disclaimer
  • The Frost & Sullivan Story
Back to Top